BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lenoir C, El Biali M, Luthy C, Grosgurin O, Desmeules JA, Rollason V. Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more? Int J Clin Pharm 2019;41:1634-41. [DOI: 10.1007/s11096-019-00929-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Scarpignato C, Tolone S. Addressing long-term PPI safety. Digestive and Liver Disease 2020;52:853-6. [DOI: 10.1016/j.dld.2020.05.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Okoro RN, Abdullahi K, Dayar DA. Assessment of proton-pump inhibitor use at a tertiary teaching hospital in Nigeria. Medicine Access @ Point of Care 2021;5:239920262110627. [DOI: 10.1177/23992026211062729] [Reference Citation Analysis]
3 Puchon E, Goboova M, Vano I, Fazekas T, Javorova-rihova Z, Kuzelova M. Medication-related factors associated with proton pump inhibitor prescription beyond official guidelines in older adults. Eur Geriatr Med 2020;11:1051-61. [DOI: 10.1007/s41999-020-00380-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Zhang Y, Yang H, Kong J, Liu L, Ran L, Zhang X, Yun J, Gu Q. Impact of interventions targeting the inappropriate use of proton-pump inhibitors by clinical pharmacists in a hepatobiliary surgery department. J Clin Pharm Ther 2021;46:149-57. [PMID: 33015848 DOI: 10.1111/jcpt.13273] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Damji SS, Rabbani SA, Rao PGM, Butt AR. Proton pump inhibitor use and appropriateness analysis: a snapshot from a secondary care hospital. Journal of Pharmaceutical Health Services Research 2021;12:206-12. [DOI: 10.1093/jphsr/rmab013] [Reference Citation Analysis]